Literature DB >> 1879100

Gastroesophageal reflux in the older child: presentation, response to treatment and long-term follow-up.

W R Treem1, P M Davis, J S Hyams.   

Abstract

Much attention has been focused on the natural history of gastroesophageal reflux (GER) in neurologically normal infants which generally resolves by two years of age. In contrast, little is known of the outcome of GER diagnosed in normal older children. The charts of 32 children (21 males) without neurologic or esophageal anatomic abnormalities, age 3.5 to 16 years (mean = 9.8) at the time of diagnosis, were reviewed. Diagnosis was based on suggestive presenting symptoms and evaluation of prolonged intraesophageal pH monitoring. Esophagitis was diagnosed by histologic criteria in 16 of the 32 patients. Medical treatment consisted of prokinetic agents (metoclopramide, bethanechol) and H2-receptor antagonists. After a one to eight year follow-up period (mean +/- SD - 3.4 +/- 2.1), the symptoms in 13 children had resolved or were sufficiently improved to discontinue medication. In 13 patients, symptoms were improved but medication was required for adequate control. Four children were symptomatic without improvement in spite of medical therapy and two others required fundoplication for continued severe symptoms and refractory esophagitis. In summary, less than 50% of otherwise normal older children with GER undergo spontaneous resolution of marked improvement in symptoms and the remainder require continued long-term medical and/or surgical management.

Entities:  

Mesh:

Year:  1991        PMID: 1879100     DOI: 10.1177/000992289103000705

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  9 in total

Review 1.  GERD in the pediatric patient: management considerations.

Authors:  David A Gremse
Journal:  MedGenMed       Date:  2004-05-05

Review 2.  Cisapride treatment for gastro-oesophageal reflux in children.

Authors:  Suzanna Maclennan; Cristina Augood; Lucinda Cash-Gibson; Stuart Logan; Ruth E Gilbert
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

3.  Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.

Authors:  Sandeep K Gupta; Eric Hassall; Yi-Lin Chiu; Fouad Amer; Melvin B Heyman
Journal:  Dig Dis Sci       Date:  2006-05-23       Impact factor: 3.199

4.  Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adults.

Authors:  Sara W Rippel; Sari Acra; Hernán Correa; Michael Vaezi; Carlo Di Lorenzo; Lynn S Walker
Journal:  Gastroenterology       Date:  2012-01-05       Impact factor: 22.682

5.  Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.

Authors:  Benjamin D Gold; James W Freston
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Histological esophagitis: clinical and histological response to omeprazole in children.

Authors:  R S Strauss; K A Calenda; Y Dayal; M Mobassaleh
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 7.  The effects and efficacy of antireflux surgery in children with gastroesophageal reflux disease: a systematic review.

Authors:  Femke A Mauritz; Maud Y A van Herwaarden-Lindeboom; Wouter Stomp; Sander Zwaveling; Katelijn Fischer; Roderick H J Houwen; Peter D Siersema; David C van der Zee
Journal:  J Gastrointest Surg       Date:  2011-07-29       Impact factor: 3.452

8.  Effects and efficacy of laparoscopic fundoplication in children with GERD: a prospective, multicenter study.

Authors:  Femke A Mauritz; J M Conchillo; L W E van Heurn; P D Siersema; C E J Sloots; R H J Houwen; D C van der Zee; M Y A van Herwaarden-Lindeboom
Journal:  Surg Endosc       Date:  2016-07-01       Impact factor: 4.584

9.  Prevalence and Epidemiological Characteristics of Endoscopically Proven Reflux Esophagitis in Children in Korea.

Authors:  Aram Yang; Ben Kang; Jae Young Choe; Hye Seung Kim; Kyunga Kim; Yon Ho Choe
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.